justaskfoundation.org
Promising Results in Tumor Shrinkage Study Announced at Neurofibromatosis Conference
Over half of patients treated with selumetinib in phase I trial see reduction in plexiform neurofibromas. New York, NY (PRWEB) June 08, 2015 As hundreds of the world’s leading NF experts conv…